Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020120
Company: LUPIN ATLANTIS
Company: LUPIN ATLANTIS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ALLERNAZE | TRIAMCINOLONE ACETONIDE | 0.05MG/SPRAY | SPRAY, METERED;NASAL | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 01/07/2009 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020120s002lbl.pdf | |
| 01/07/2009 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020120s002lbl.pdf | |
| 02/04/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20120lbl.pdf |